Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.
Clinical trial NCT07291323 · RECRUITING
Trial details
- NCT number
- NCT07291323
- Sponsor
- Janux Therapeutics
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-16
- Primary completion
- 2026-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.